Emergency use of Corona vaccine Kovishield has been approved in the country. Corona vaccination campaign will be started in India from 6 January. The Kovishield vaccine to be made at the Serum Institute of India has been approved by the Expert Committee of the Central Drug Standards Control Organization.

However, the Kovishield vaccine is yet to get the final approval from the Drug Controller of India. The Serum Institute of India is preparing the Oxford-AstraZeneca vaccine in India.

The 10-member Subject Expert Committee of India’s Central Drug Standards Control Organization on Friday approved the Emergency Use Authority of the Oxfodz-AstraZeneca Coronavirus Vaccine Covishield. The expert panel convened a meeting on behalf of the Serum Institute of India to decide on the Emergency Use Authority sought by Kovshield and Bharat Biotech for covacine.

Once the way has been cleared for the vaccine from the committee, the application for final approval will be sent to DCGI VG Somani. The Health Ministry said that the decision on Bharat Biotech’s covarine is still awaited.

Significantly, on December 6, the Serum Institute of India applied to the DCGI for obtaining formal approval for the emergency use of the Kovid-19 vaccine Kovishield of Oxford in India. Earlier, DCGI VG Somani indicated that Kovid-19 vaccine could come in India in the new year.